Gilead Sciences Inc (GILD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,170,000 | 5,613,000 | 4,196,000 | 2,024,000 | 985,000 |
| Depreciation Amortization | 690,000 | 2,693,000 | 2,005,000 | 1,321,000 | 640,000 |
| Income taxes - deferred | -723,000 | -962,000 | -592,000 | -524,000 | -303,000 |
| Accounts receivable | -66,000 | 157,000 | -63,000 | 549,000 | 635,000 |
| Accounts payable and accrued liabilities | 72,000 | -347,000 | -304,000 | -275,000 | -272,000 |
| Other Working Capital | -459,000 | -2,303,000 | -1,760,000 | -211,000 | -542,000 |
| Other Operating Activity | 6,875,000 | 3,155,000 | 2,355,000 | 1,198,000 | 601,000 |
| Operating Cash Flow | $2,219,000 | $8,006,000 | $5,837,000 | $4,082,000 | $1,744,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,348,000 | -86,000 | -77,000 | -69,000 | -36,000 |
| PPE Investments | -105,000 | -585,000 | -370,000 | -248,000 | -109,000 |
| Net Acquisitions | -4,043,000 | -1,152,000 | -873,000 | -794,000 | -551,000 |
| Purchase Of Investment | -410,000 | -442,000 | -218,000 | -192,000 | -125,000 |
| Other Investing Activity | 3,000 | 0 | 0 | -6,000 | -5,000 |
| Investing Cash Flow | $-2,207,000 | $-2,265,000 | $-1,538,000 | $-1,309,000 | $-826,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,980,000 | 1,979,000 | N/A | N/A |
| Debt Repayment | N/A | -2,250,000 | -2,250,000 | N/A | N/A |
| Common Stock Issued | 146,000 | 232,000 | 206,000 | 123,000 | 97,000 |
| Common Stock Repurchased | -400,000 | -1,000,000 | -850,000 | -550,000 | -400,000 |
| Dividend Paid | -990,000 | -3,809,000 | -2,866,000 | -1,913,000 | -969,000 |
| Other Financing Activity | -117,000 | -278,000 | -245,000 | -167,000 | -134,000 |
| Financing Cash Flow | $-1,361,000 | $-5,125,000 | $-4,026,000 | $-2,507,000 | $-1,406,000 |
| Exchange Rate Effect | -18,000 | 57,000 | 20,000 | 26,000 | 13,000 |
| Beginning Cash Position | 6,085,000 | 5,412,000 | 5,412,000 | 5,412,000 | 5,412,000 |
| End Cash Position | 4,718,000 | 6,085,000 | 5,705,000 | 5,704,000 | 4,936,000 |
| Net Cash Flow | $-1,367,000 | $673,000 | $293,000 | $292,000 | $-476,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,219,000 | 8,006,000 | 5,837,000 | 4,082,000 | 1,744,000 |
| Capital Expenditure | -105,000 | -585,000 | -370,000 | -248,000 | -109,000 |
| Free Cash Flow | 2,114,000 | 7,421,000 | 5,467,000 | 3,834,000 | 1,635,000 |